Welcome to our dedicated page for Microvast Holdings SEC filings (Ticker: MVST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Microvast Holdings, Inc. (MVST) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and registration-related filings that together outline Microvast’s financial condition, governance, and capital markets activity.
Microvast is a battery technology company focused on lithium-ion solutions for electric vehicles and energy storage systems. Its filings describe key aspects of the business, such as revenue trends, gross margins, operating expenses, net income or loss, cash balances, and the use of non-GAAP measures like adjusted EBITDA, adjusted gross margin, and adjusted operating expenses. Risk factor sections and cautionary statements in these reports discuss uncertainties related to remaining a going concern, executing growth strategies, manufacturing capacity, supply chains, operations in China, litigation, regulatory changes, and macroeconomic and geopolitical conditions.
Current reports on Form 8-K capture material events such as quarterly earnings announcements, equity offering agreements, changes in executive leadership, and outcomes of annual stockholder meetings. For example, Microvast has filed 8-Ks describing the appointment of an interim chief financial officer, the departure of a chief financial officer, the results of its 2025 annual meeting, and the entry into a Controlled Equity OfferingSM Sales Agreement under an effective shelf registration statement.
The definitive proxy statement on Schedule 14A details corporate governance and stockholder matters, including board composition, director elections, auditor ratification, executive compensation, and voting procedures. Investors can also review information on the listing of Microvast’s common stock and redeemable warrants on the Nasdaq Capital Market under the symbols MVST and MVSTW.
Stock Titan’s platform enhances these filings with AI-powered summaries that explain the significance of lengthy reports, highlight important changes from prior periods, and surface key items such as revenue dynamics, risk disclosures, capital-raising transactions, and governance decisions. Users can quickly scan new 10-K, 10-Q, 8-K, and proxy filings, as well as monitor registered offerings and related legal opinions, without reading every page of the underlying documents.
Microvast Holdings, Inc. furnished materials summarizing its unaudited condensed consolidated financial results for the period ended September 30, 2025. On November 10, 2025, the company announced a press release and an accompanying slideshow presentation outlining its Q3 2025 results.
The press release is provided as Exhibit 99.1 and the presentation as Exhibit 99.2. The information is furnished, not filed, and is therefore not subject to Section 18 liabilities of the Exchange Act, nor incorporated by reference into other filings except as specifically referenced.
Microvast Holdings (MVST) filed its Q3 2025 report, showing higher sales but continued bottom-line pressure and liquidity risks. Revenue rose to $123.3 million (from $101.4 million), lifting gross profit to $46.4 million. Operating income was $13.0 million, but a non-cash fair value loss on its convertible loan drove a net loss of $1.5 million.
For the nine months, revenue reached $331.1 million (from $266.4 million) with net cash from operating activities of $59.5 million. Cash and cash equivalents were $90.7 million plus $51.9 million in restricted cash as of September 30, 2025. Total liabilities were $655.5 million and equity $358.1 million.
The company disclosed conditions that raise substantial doubt about its ability to continue as a going concern, citing short-term debt and commitments. Management points to positive operating cash flow, refinancing activity, and an at‑the‑market equity program; after quarter‑end, it received $12.6 million in net proceeds under a Sales Agreement. Bank borrowings totaled $118.8 million (with $84.4 million current), and the fair value of the convertible loan was $193.5 million.
Microvast Holdings, Inc. reported the results of its 2025 Annual Meeting of stockholders held on October 23, 2025. A total of 192,887,067 shares were present, representing approximately 59.28% of the 325,354,111 shares outstanding as of August 26, 2025.
Stockholders elected director nominee Wei Ying with 123,485,834 votes for, 13,349,205 withheld, and 55,865,084 broker non‑votes. Stockholders also approved a separate proposal with 191,591,011 for, 1,176,675 against, and 119,381 abstentions.
Microvast Holdings, Inc. (MVST) discloses multiple outstanding and potentially dilutive securities and a broad set of material risk factors. The prospectus lists 29,020,343 shares issuable on outstanding stock options at a weighted-average exercise price of $5.72, 4,014,008 restricted stock units, 28,437,000 shares issuable on warrants at an exercise price of $11.50, 5,500,000 shares issuable on a CEO warrant at $2.00, and 50,000,000 shares issuable upon conversion of a convertible loan related to a Loan Agreement.
The filing highlights significant business risks, including concerns about the company’s ability to remain a going concern, the need for additional capital, manufacturing scale-up and quality risks, exposure to operations in China, mechanics liens, litigation, macroeconomic and supply-chain pressures, customer concentration and demand uncertainty, cybersecurity and regulatory compliance costs, and potential adverse effects of tariffs on China imports. The prospectus incorporates prior SEC filings for additional detail.
Microvast Holdings, Inc. entered into a Controlled Equity OfferingSM Sales Agreement that allows it to sell from time to time up to $125,000,000 of its common stock through Cantor Fitzgerald & Co. and Needham & Company, LLC as sales agents or principal. These sales will be made as at-the-market offerings under an effective shelf registration statement on Form S-3.
The company will pay the agents a commission of up to 3.0% of the aggregate gross proceeds from any sales. Microvast plans to use the net proceeds for general corporate purposes, which may include repaying or refinancing indebtedness, funding acquisitions, capital expenditures and working capital.
Microvast Holdings provides voting instructions for its 2025 Annual Meeting, allowing stockholders of record and beneficial owners to vote via the Internet, by mail, or virtually during the live webcast. Proxies can be revoked and changed before the meeting by submitting a new Internet vote or a later-dated signed proxy or voting instruction form; beneficial owners must obtain a control number from their nominee to vote virtually.
The Board reduced its size from seven to five on August 25, 2025, and now has three independent directors (Yixin Pan, Wei Ying and Arthur Wong) out of five. Proposal No. 2 seeks ratification of Deloitte as the independent registered public accounting firm for Fiscal 2025 and requires a majority of votes cast to approve; abstentions will count the same as votes against. Broadridge will serve as inspector of election and the Company will pay solicitation costs.
Microvast Holdings, Inc. reported higher sales and stronger operating results but remained loss-making after large financing remeasurements and legal contingencies. Revenue for the quarter ended June 30, 2025 was $91.3 million, up from $83.7 million a year earlier, and six-month revenue rose to $207.8 million from $165.0 million, reflecting broader regional sales. Gross profit for the quarter was $31.7 million (versus $27.2 million). Operating income improved to $16.2 million for the quarter and $35.1 million for six months, reversing prior-period operating losses largely because operating expenses, including impairments, declined.
Despite operating improvement, the company recorded a quarterly net loss of $106.1 million driven by a non-cash $121.5 million adverse fair-value change in warrant and convertible loan liabilities; six-month net loss narrowed to $44.3 million from $126.4 million a year earlier. Cash and equivalents rose to $99.7 million with total cash and restricted cash of $138.8 million. Current liabilities increased materially to $524.7 million, including a $181.5 million convertible loan measured at fair value and $83.2 million in short-term bank borrowings. Management discloses substantial doubt about going concern but believes forecasted operating cash flows and historical refinancing support its plans. The filing also discloses multiple securities and derivative litigations and other contract disputes.
Microvast Holdings appointed Rodney Worthen as Interim Chief Financial Officer, effective immediately. He will continue to serve as the companys Vice President of Corporate Strategy while assuming the interim CFO responsibilities. Mr. Worthen, age 34, joined Microvast in June 2023 and has held roles including Director of Investor Relations and FP&A, Vice President of Corporate Finance, and Head of FP&A and Investor Relations.
Before joining Microvast he served as Director of Finance at Killam Holdings Company and held M&A, FP&A and engineering roles at private and publicly listed energy companies. His academic credentials include a B.S. in Mechanical Engineering, an M.S. in Engineering, an M.S. in Finance and an MBA. The filing states there are no arrangements or family relationships related to the appointment and includes Exhibit 104 (Inline XBRL cover page data).